Cortisone-Free Topical Plan
A cortisone-free topical plan combines calcineurin inhibitors, PDE-4 inhibitors and ceramide barrier repair to control inflammation without steroid side effects.
Clinic and treatment images
Tap to enlargeHow it is applied
Calcineurin inhibitors are used on sensitive sites such as the face, eyelids and folds.
PDE-4 inhibitors target inflammation to ease itch and redness without any cortisone.
Ceramide-based moisturisers repair the skin barrier within a planned daily routine.
Response is monitored and stepped up to phototherapy or systemic options if needed.
Who it suits
- Involvement of sensitive sites such as face, eyelids and folds where steroids are unsuitable.
- Psoriasis and eczema patients who wish to avoid prolonged topical steroid use.
- Children and thin-skinned areas needing a safe long-term maintenance treatment.
Calcineurin inhibitors may cause brief stinging in the first days; the plan is personalised to skin site and age.
Why Clinovia?
Psoriasis and eczema are not only a surface problem. We assess the skin barrier, inflammation, nutrition and lifestyle, comorbidities and dermatological treatment together. Evidence-based dermatology remains the backbone; nutrition and lifestyle support that plan.
The Gut–Skin Relationship
We review digestive symptoms, dietary pattern and food-sensitivity history. The link between gut microbiome and inflammatory skin disease is still being researched, so it is addressed alongside — never instead of — dermatological treatment.
Cortisone-Free Protocol
First-line calcineurin and PDE-4 inhibitors, ceramide-based barrier repair and phototherapy instead of steroids; systemic and biologic steps when needed.
Systemic Repair
Vitamin D, zinc, omega-3 and iron levels plus thyroid and insulin resistance are screened, and any deficits found are built into the plan.
Measurable Follow-up
PASI/EASI and DLQI scores are tracked alongside laboratory values; steps that do not deliver a response are removed from the plan.
Our standard protocols are cortisone-free. We work with topical calcineurin inhibitors, PDE-4 inhibitors, ceramide-based barrier repair, NB-UVB phototherapy and biologic agents when needed. Cortisone is considered only for very short, unavoidable situations and with the patient's consent.
NB-UVB is safe when cumulative dose is monitored. A typical course is 20–30 sessions at two to three per week; the first response usually appears within 4–6 weeks.
Patients with moderate-to-severe psoriasis or severe atopic dermatitis who did not respond adequately to phototherapy and systemic therapy. Eligibility is confirmed after screening tests.
All treatments
NB-UVB PhototherapyNarrowband UVB at 311 nm calms inflammation in psoriasis and eczema without cortisone. Sessions run two to three times a week, with a typical course of 20–30 and PASI/EASI tracking.
Learn more
PUVA & Targeted PhototherapyPUVA and targeted local units treat stubborn sites such as hands, feet and scalp with cortisone-free light. Dose and response are monitored throughout the course.
Learn more
Biologic TreatmentsBiologic drugs selectively block targets such as IL-17 and IL-23 in psoriasis and IL-4/13 in eczema. They are considered in moderate-to-severe, resistant disease after screening.
Learn more
Let's build the right plan for your skin today
Fill in the form and our coordinator will call you the same day to arrange the right doctor and time slot.
- Same-day callback
- Consultation in five languages
- Written treatment plan
- Defterdar, Fethi Çelebi Cd. No:15, 34050 Eyüpsultan/İstanbul, Türkiye
- Mon–Sat: 09:00 – 19:00